Antibodies against human papillomavirus (HPV) type 16 and 18 E2, E6 and E7 proteins in sera: Correlation with presence of papillomavirus DNA

Journal of Medical Virology

Volumn 65, Issue 4, 2001, Pages 736-744

  Rosales, Ricardo ^a,c   López Contreras, Mario ^b,c   Cortes, Roberto Risco ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b HOSPITAL JUÁREZ DE MÉXICO   (Mexico)

^c INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

Author keywords

Cervical cancer; Cervix; Cryosurgery; Hybrid Capture; Synthetic peptide

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS DNA; VIRUS PROTEIN; VIRUS PROTEIN E2; VIRUS PROTEIN E6; VIRUS PROTEIN E7;

ADOLESCENT; ADULT; AGE; AGED; ANTIBODY TITER; ARTICLE; COLPOSCOPY; CONTROLLED STUDY; CRYOSURGERY; DNA REPLICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOGENE; PAPANICOLAOU TEST; SERUM; SEXUALITY; UTERINE CERVICITIS; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; VIRUS INFECTION; WART VIRUS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; BIOPSY; CERVIX UTERI; DNA, VIRAL; DNA-BINDING PROTEINS; FEMALE; HUMANS; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRUS;

EID: 0035214347     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.2098     Document Type: Article

References (41)

1. Humoral immune response against proteins E6 and E7 in cervical carcinoma patients positive for papillomavirus type 16 during treatment and follow-up
2. Comparison of human papillomavirus type 16, 18, and 6 capsid antibody responses following incident infection
3. Immunologic diagnosis and monitoring of cervical cancers using in vitro translated HPV proteins
4. A synthetic peptide defines a serologic IgA response to a human papillomavirus-encoded nuclear antigen expressed in virus-carrying cervical neoplasia
5. Detection of IgA antibodies against human papillomavirus in cervical secretions from patients with cervical intraepithelial neoplasia
6. Papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions
7. The association of human papillomavirus type 16 E6 and E7 antibodies with stage of cervical cancer
8. Characterization of the humoral immune response to genital papillomaviruses
9. Early promoters of genital and cutaneos human papillomaviruses are differentially regulated by the bovine papillomavirus type 1 E2 gene product
10. Molecular mechanism of carcinogenesis by human papillomavirus-16
11. Identification of immunoreactive antigens of human papillomavirus type 6b by using Escherichia coli-expressed fuson proteins
12. Antibodies against the human papillomavirus type 16 early proteins in human sera: Correlation of anti-E7 reactivity with cervical cancer
13. The antibody response to HPV proteins and the genomic state of HPVs in patients with cervical cancer
14. High-risk human papillomavirus is sexually transmitted: Evidence from a follow-up study of virgins starting sexual activity (intercourse)
15. Ocurrence of antibodies to L1, L2, E4, and E7 gene products of human papillomavirus type 6b, 16 and 18 among cervical cancer patients and controls
16. Pre- and posttreatment serum responses to HPV 16 E2 and HSV 2 ICP8 proteins in women with cervical carcinoma
17. Identification of human papillomavirus type 6b L1 open reading frame protein in condylomas and corresponding antibodies in human sera
18. Identification of the human papilomavirus E2 protein in genital tract tissue
19. Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invesive cervical cancer
20. The causal link between HPV and cervical cancer and its implications for prevention of cervical cancer
21. Cervical cancer and human papillomavirus: Epidemiological evidence and perspectives for prevention
22. The causal link between human papillomavirus and invasive cervical cancer: A population study based in Colombia and Spain
23. Antibodies against linear and conformational epitopes of the human papillomavirus (HPV) type 16 E6 and E7 oncoproteins in sera of cervical cancer patients
24. Association of the antibodies against human papillomavirus 16 E4 and E7 proteins with cervical cancer positive for human papillomavirus DNA
25. High prevalence of serum antibodies to Ras and tepy 16 E4 proteins of human papillomavirus in patients with precancerous lesions of the utherine cervix
26. Antibodies to human papillomavirus type 16 in patients with cervical neoplasia
27. Prevalence of serum antibodies of synthetic peptides to HPV16 epitopes among Indian women with cervical neoplasia
28. Human papillomavirus-related serological markers of invasive cervical carcinoma in Brazil
29. Serum antibodies to human papillomavirus 16 proteins in women from Brazil with invasive cervical carcinoma
30. Functional analysis of E2-mediated repression of the HPV18 P105 promoter
31. Characterization of human papillomavirus types in condylomata acuminata in children by in situ hybridization
32. Immunoglobulin A, G and M, responses to L1 and L2 capsids of human papillomavirus types 6, 11, 16, 18, and 33 L1 after newly acquired infection
33. Serologic response in human papillomavirus-associated invasive cervical cancer
34. Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among college women
35. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
36. Seroepideniology of human papillomavirus type 73: A sexually transmitted low-risk virus
37. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in patients with head-and-neck squamous-cell carcinoma
38. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervicalcarcinoma patients from Russia
39. Papillomavirus in anogenital cancer: The dilemma of epidemiologic approaches
40. The role of papillomavirus in human anogenital cancer